Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Plains GP Holdings, L.P.LTD PARTNR INT A(PAGP) | 1,272,360 | 1,272,360 | 0 | $24.35M | $30.18M | 19.02% | +$5.83M |
| Achieve Life Sciences Inc | 3,786,425 | 3,786,425 | 0 | $18.82M | $11.37M | 7.17% | -$7.45M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 740,918 | 841,272 | +100,354 | $12.29M | $9.35M | 5.90% | -$2.94M |
| Delcath Systems, Inc.(DCTH) | 438,509 | 979,698 | +541,189 | $4.43M | $9.16M | 5.77% | +$4.73M |
| Corcept Therapeutics Incorporated(CORT) | 0 | 147,828 | +147,828 | $0 | $6.02M | 3.80% | +$6.02M |
| Abeona Therapeutics Inc.(ABEO) | 830,780 | 1,329,899 | +499,119 | $4.38M | $6.01M | 3.79% | +$1.63M |
| Vor Biopharma Inc.(VOR) | 0 | 314,543 | +314,543 | $0 | $5.59M | 3.52% | +$5.59M |
| Kyverna Therapeutics, Inc.(KYTX) | 666,666 | 644,421 | -22,245 | $6.27M | $5.59M | 3.52% | -$681.1K |
| Milestone Pharmaceuticals Inc.(MIST) | 4,118,321 | 4,118,321 | 0 | $8.32M | $5.08M | 3.20% | -$3.24M |
| Celldex Therapeutics, Inc.(CLDX) | 154,300 | 131,364 | -22,936 | $4.19M | $4.14M | 2.61% | -$55.7K |
| COMPASS Pathways plcADS(CMPS) | 861,778 | 742,049 | -119,729 | $5.95M | $4.12M | 2.60% | -$1.83M |
| Viridian Therapeutics, Inc.(VRDN) | 282,531 | 210,163 | -72,368 | $8.79M | $4.09M | 2.58% | -$4.70M |
| Inventiva S.A.ADS(IVA) | 1,000,000 | 724,678 | -275,322 | $4.65M | $3.99M | 2.52% | -$655.4K |
| SAB Biotherapeutics, Inc.(SABS) | 652,881 | 1,012,790 | +359,909 | $2.44M | $3.89M | 2.45% | +$1.44M |
| Orchestra BioMed Holdings, Inc.(OBIO) | 0 | 896,701 | +896,701 | $0 | $3.83M | 2.41% | +$3.83M |
| 4d Molecular Therapeutics In | 0 | 380,420 | +380,420 | $0 | $3.58M | 2.26% | +$3.58M |
| Oculis Holding AG(OCS) | 172,839 | 122,223 | -50,616 | $3.45M | $3.28M | 2.07% | -$172.4K |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 382,375 | +382,375 | $0 | $3.23M | 2.03% | +$3.23M |
| Upstream Bio, Inc.(UPB) | 0 | 341,779 | +341,779 | $0 | $3.10M | 1.95% | +$3.10M |
| Aquestive Therapeutics Inc | 0 | 710,988 | +710,988 | $0 | $2.95M | 1.86% | +$2.95M |
| EyePoint, Inc.(EYPT) | 0 | 215,825 | +215,825 | $0 | $2.79M | 1.76% | +$2.79M |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 223,802 | +223,802 | $0 | $2.65M | 1.67% | +$2.65M |
| Zevra Therapeutics, Inc.(ZVRA) | 63,683 | 282,418 | +218,735 | $570.6K | $2.64M | 1.66% | +$2.07M |
| Immunic, Inc.(IMUX) | 0 | 2,344,779 | +2,344,779 | $0 | $2.62M | 1.65% | +$2.62M |
| Coherus Oncology, Inc.(CHRS) | 0 | 1,420,550 | +1,420,550 | $0 | $2.41M | 1.52% | +$2.41M |
| Ovid Therapeutics Inc.(OVID) | 0 | 921,457 | +921,457 | $0 | $2.04M | 1.28% | +$2.04M |
| Palisade Bio, Inc.(PALI) | 0 | 1,115,000 | +1,115,000 | $0 | $2.00M | 1.26% | +$2.00M |
| Kalaris Therapeutics, Inc.(KLRS) | 42,053 | 295,771 | +253,718 | $354.9K | $1.72M | 1.08% | +$1.37M |
| uniQure N.V.SHS(QURE) | 0 | 104,772 | +104,772 | $0 | $1.71M | 1.08% | +$1.71M |
| LeonaBio, Inc.(LONA) | 149,279 | 149,279 | 0 | $1.13M | $1.50M | 0.94% | +$365.7K |
| Nuvation Bio Inc.CL A(NUVB) | 0 | 329,296 | +329,296 | $0 | $1.41M | 0.89% | +$1.41M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 43,798 | +43,798 | $0 | $1.31M | 0.82% | +$1.31M |
| Evommune, Inc.(EVMN) | 0 | 55,664 | +55,664 | $0 | $1.28M | 0.81% | +$1.28M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 0 | 85,791 | +85,791 | $0 | $1.25M | 0.79% | +$1.25M |
| Aldeyra Therapeutics, Inc.(ALDX) | 0 | 730,606 | +730,606 | $0 | $1.23M | 0.78% | +$1.23M |
| Artiva Biotherapeutics, Inc.(ARTV) | 0 | 146,369 | +146,369 | $0 | $949.8K | 0.60% | +$949.8K |
| Connect Biopharma Holdings LimitedSHS(CNTB) | 0 | 209,493 | +209,493 | $0 | $553.9K | 0.35% | +$553.9K |
| Satellos Bioscience Inc.(MSLE) | 0 | 10,145 | +10,145 | $0 | $57.1K | 0.04% | +$57.1K |
| Aardvark Therapeutics Inc | 46,408 | 0 | -46,408 | $609.1K | $0 | — | -$609.1K |
| LENZ Therapeutics, Inc.(LENZ) | 59,085 | 0 | -59,085 | $945.4K | $0 | — | -$945.4K |
| REGENXBIO Inc.(RGNX) | 116,896 | 0 | -116,896 | $1.68M | $0 | — | -$1.68M |
| Nektar Therapeutics(NKTR) | 82,822 | 0 | -82,822 | $3.50M | $0 | — | -$3.50M |